Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Compare tax exposure between dividend ETFs and taxable funds in 2024 to identify the lower-tax option for your goals.
28,172 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Meta's plan to price AR glasses at $300 could be a turning point for investors. This article breaks down the potentia...
Analysts reveal a skewed distribution in Pi token ownership, highlighting a small number of mega-holders and a vast m...
Bitcoin options totaling roughly $2B are set to expire Friday, with markets flat and volatility subdued. Traders are ...
In the wake of after $679 million iran bets, lawmakers are moving to curb and potentially ban prediction markets tied...
Playnance has kicked off GCOIN trading on MEXC, signaling a key expansion of its Web3 entertainment network. Early me...
BuzzFeed wins a brief reprieve on a $5 million debt due May 18, after a prior going-concern warning. The move spooks ...
A former Kremlin insider says Moscow’s ruling circle is rethinking loyalty to Putin as asset seizures rise and inflat...
As incoming Fed Chair Warsh signals a renewed focus on inflation, traders weigh the odds of higher-for-longer policy ...
Intel shares jumped on a new Hitachi pact, fueling speculation that Google and NVIDIA could lean on Intel Foundry for...
Cardano faces a pivotal test as founder Charles Hoskinson lays out a four-layer rescue plan blending governance refor...
Aave's price surge near $94.32 on June 27 sparked talk that DeFi lending is entering a bank-like phase, with governan...